Cambridge-Based Moderna Says Its COVID Vaccine is 94.5% Effective
editor The following press release comes from the business wire service, SOURCE digital news media uses. *** CAMBRIDGE – Moderna, Inc. , biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines…